Timeintensity相关论文
Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unr
BACKGROUND Lenvatinib is one of the first-line tyrosine kinase inhibitors used for unresectable hepatocellular carcinoma......